MAPT and dementia: Together, CSF biomarkers of amyloid pathology (Aβ1-42), tangle pathology (P-tau) and cortical axonal degeneration (T-tau) identify AD with dementia and prodromal AD in patients with MCI with 75–95% sensitivity and specificity [33–36].